IN VITRO DRUG RELEASE (IVR)
IVR tests are part of the pharmaceutical industry, aimed to quantify drug release kinetics during pharmaceutical development. Current IVR methodologies are resource intensive processes and consist of laborious, time-consuming and repetitive tasks. In addition, in vivo studies are needed to establish a correlation with the IVR tests.
As the price of drug development continues to soar, there is great need for new approaches that can improve upon the predictive quality and operational efficiency of in vitro testing. We are developing an innovative model for IVR testing systems with microfluidics technology.
Our MC Fluidics team is setting up innovative tools to implement an optimized and automated process for lead formulations research. This helps not only to optimize resource management, but also to draw parallels between the various tests and to achieve economies of scale.
We’re always looking for new talent
The people of MedinCell aren’t just creating life-sustaining products- their aim is to revolutionize the patient’s way of life. Interested in being part of a self-funded, employee owned, creative workplace? Take a look at what our employees had to say.